Abnormal constitutional karyotypes in patients with neuroblastoma: A report of four new cases and review of 47 others in the literature

Cancer Genetics and Cytogenetics

Volumn 147, Issue 2, 2003, Pages 89-98

  Satgé, Daniel ^a   Moore, Sam W ^b   Stiller, Charles A ^c   Niggli, Félix K ^d   Pritchard Jones, Kathy ^e   Bown, Nick ^f   Bénard, Jean ^g   Plantaz, Dominique ^h  

^a CENTRE HOSPITALIER   (France)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f Institute for Human Genetics   (United Kingdom)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; CHROMOSOME 11Q; CHROMOSOME 15Q; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 21; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 9P; CHROMOSOME DELETION; CHROMOSOME DELETION 11Q; CHROMOSOME INVERSION 9; CHROMOSOME MAP; CHROMOSOME MOSAICISM; CLINICAL FEATURE; DOWN SYNDROME; FEMALE; HUMAN; INFANT; KARYOTYPE; KARYOTYPE 47,XXX; KLINEFELTER SYNDROME; MALE; MONOSOMY; MONOSOMY 22; NEUROBLASTOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; ROBERTSONIAN CHROMOSOME TRANSLOCATION; TRISOMY 13; TRISOMY 21; TURNER SYNDROME; X CHROMOSOME;

ROBERTSONIA;

EID: 0242575113     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00203-6     Document Type: Article

References (101)

1. Yunis J.J., Ramsay N. Retinoblastoma and subband deletion of chromosome 13. Am J Dis Child. 132:1978;161-163.
2. Riccardi V.M., Sujansky E., Smith A.C., Francke U. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics. 61:1978;604-610.
3. Francke U., Holmes L.B., Atkins L., Riccardi V.M. Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet. 24:1979;185-192.
4. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M., Dryja T.P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646.
5. Gessler M., Poustka A., Cavenee W., Neve R.L., Orkin S.H., Bruns G.A.P. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 343:1990;774-778.
6. Brodeur G.M., Fong C. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet. 41:1989;153-174.
7. Laureys G., Speleman F., Opdenakker G., Benoit Y., Leroy J. Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosomes Cancer. 2:1990;252-254.
8. Biegel J.A., White P.S., Marshall H.N., Fujimori M., Zackai E.H., Scher C.D., Brodeur G.M., Emanuel B.S. Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet. 52:1993;176-182.
9. Brodeur G.M., Sekhon G.S., Goldstein M.N. Chromosomal aberrations in human neuroblastomas. Cancer. 40:1977;2256-2263.
10. Gilbert F., Balaban G., Moorhead P., Bianchi D., Schlesinger H. Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet Cytogenet. 7:1982;33-42.
11. Gilbert F., Feder M., Balaban G., Brangman D., Lurie D.K., Podolsky R., Rinaldt V., Vinikoor N., Weisband J. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res. 44:1984;5444-5447.
12. Martinsson T., Sjöberg R.-M., Hedborg F., Kogner P. Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma. Cancer Genet Cytogenet. 95:1997;183-189.
13. Wakonig-Vaartaja T., Helson L., Baren A., Koss L.G., Murphy M.L. Cytogenetic observations in children with neuroblastoma. Pediatrics. 47:1971;839-843.
14. Lampert F., Rudolph B., Christiansen H., Franke F. Identical chromosome 1p breakpoint abnormality in both the tumor and the constitutional karyotype of a patient with neuroblastoma. Cancer Genet Cytogenet. 34:1988;235-239.
15. Blatt J., Olshan A.F., Lee P.A., Ross J.L. Neuroblastoma and related tumors in Turner's syndrome. J Pediatr. 131:1997;666-670.
16. Brodeur G.M. Clinical and biological aspects of neuroblastoma. Fernbach D.J., Vretti J.J. Clinical pediatric oncology. 4th edition:1991;691-707 Mosby Year Book, St Louis.
17. Price W.H., Clayton J.F., Wilson J., Collyer S., De Mey R. Causes of death in X chromatin positive males (Klinefelter's syndrome). J Epidemiol Community Health. 39:1985;330-336.
18. Hasle H., Mellemgaard A., Nielsen J., Hansen J. Cancer incidence in men with Klinefelter syndrome. Br J Cancer. 71:1995;416-420.
19. Hsu L.Y.F. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. Milunski A. Genetic disorders and the fetus: diagnosis, prevention, and treatment. 1998;179-180 Johns Hopkins University Press, Baltimore, MD.
20. Plantaz D. Etude cytogénétique moléculaire du neuroblastome de l'enfant par hybridation génomique comparative. Thesis sciences, University of Grenoble, 1999.
21. Satgé D., Sasco A.J., Plantaz D., Bénard J., Vekemans M. Abnormal number of X chromosomes and neuroblastic tumors. J Pediatr Hematol Oncol. 23:2001;331-332.
22. Koyama T., Kanadani T., Tanaka M., Nakahara S., Yamadori I. A case of Down's syndrome associated with progressive extradural neuroblastoma. Pediatr Surg Int. 15:1999;373-375.
23. Satgé D., Rubie H., Sommelet D. A paravertebral neoplasm in a child with Down syndrome. Pediatr Surg Int. 17:2001;588.
24. Satgé D., Sasco A.J., Carlsen N.L.T., Stiller C.A., Rubie H., Hero B., de Bernardi B., de Kraker J., Coze C., Kogner P., Langmark F., Hakvoort-Cammel F.G.A.J., Beck D., von der Weid N., Parkes S., Hartmann O., Lippens R.J.J., Kamps W.A., Sommelet D. A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res. 58:1998;448-452.
25. Satgé D., Sommelet D., Geneix A., Nishi M., Malet P., Vekemans M. A tumor profile in Down syndrome. Am J Med Genet. 78:1998;207-216.
26. Hasle H., Clemmensen I.H., Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet. 355:2000;165-169.
27. Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol. 2:2001;429-436.
28. Satgé D., Sasco A.J., Pujol H., Réthoré M.-O. Les cancers mammaires des femmes trisomiques 21. Bull Acad Natl Med. 185:2001;1239-1254.
29. Winningham-Major F., Staecker J.L., Barger S.W., Coats S., Van Eldik L.J. Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues. J Cell Biol. 109:1989;3063-3071.
30. Satgé D. A decreased incidence of neuroblastomas in Down's syndrome and overproduction of S-100B protein. Med Hypotheses. 46:1996;393-399.
31. Zorick T.S., Mustacchi Z., Yumi Bando S., Zatz M., Moreira-Filho C.A., Olsen B., Passos-Bueno M.R. High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours. Eur J Hum Genet. 9:2001;811-814.
32. Jones K.L. Trisomy 18 syndrome; Trisomy 13 syndrome. Jones K.L. Smith's recognizable patterns of human malformation. 5th edition:1997;14-15 WB Saunders, Philadelphia, PA. 18-19.
33. Moorhead P.S., Evans A.E. Chromosomal findings in patients with neuroblastoma. Evans A.E. Advances in neuroblastoma research. Progress in Cancer Research and Therapy. Volume 12:1980;109-118 Raven Press, New York.
34. Bown N.P., Pearson A.D.J., Reid M.M. High incidence of constitutional balanced translocations in neuroblastoma. Cancer Genet Cytogenet. 69:1993;166-167.
35. Lurie I.W., Ilyina H.G., Gurevich D.B., Rumyantseva N.V., Naumchik I.V., Castellan C., Hoeller A., Schinzel A. Trisomy 2p: analysis of unusual phenotypic findings. Am J Med Genet. 55:1995;229-236.
36. Seven M., Karaman B., Hacihanefioglu S., Deviren A., Yuksel A., Basaran S. Neuroblastoma in a dysmorphic girl with a partial duplication of 2p caused by an unbalanced translocation. Clin Dysmorphol. 11:2002;39-42.
37. Schwab M., Alitalo K., Klempnauer K.-H., Varmus H.E., Bishop J.M., Gilbert F., Brodeur G.M., Goldstein M., Trent J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature. 305:1983;245-248.
38. Brodeur G.M., Seeger R.C., Schwab M., Varmus H.E., Bishop J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 224:1984;1121-1124.
39. Bown N. Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol. 54:2001;897-910.
40. Weiss W.A., Aldape K., Mohapatra G., Feuerstein B.G., Bishop J.M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16:1997;2985-2995.
41. Corvi R., Savelyeva L., Schwab M. Patterns of oncogene activation in human neuroblastoma cells. J Neurooncol. 31:1997;25-31.
42. Van Roy N., Van Limbergen H., Vandesompele J., Van Gele M., Poppe B., Laureys G., De Paepe A., Speleman F. Chromosome 2 short arm translocations revealed by M-FISH analysis of neuroblastoma cell lines. Med Pediatr Oncol. 35:2000;538-540.
43. Vandesompele J., Speleman F., Van Roy N., Laureys G., Brinkschmidt C., Christiansen H., Lampert F., Lastowska M., Bown N., Pearson A., Nicholson J., Ross F., Combaret V., Delettre O., Feuerstein B.G., Plantaz D. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol. 36:2001;5-10.
44. Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol. 24:1995;215-221.
45. Bown N., Cotterill S., Lastowska M., O'Neill S., Pearson A.D.J., Plantaz D., Meddeb M., Danglot G., Brinkschmidt C., Christiansen H., Laureys G., Speleman F. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 340:1999;1954-1961.
46. Caron H., Van Sluis P., De Kraker J., Bökkerink J., Egeler M., Laureys G., Slater R., Westerveld A., Voûte P.A., Versteeg R. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med. 334:1996;225-230.
47. Shapira S.K., McCaskill C., Northrup H., Spikes A.S., Elder F.F.B., Sutton V.R., Korenberg J.R., Greenberg F., Shaffer L.G. Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet. 61:1997;642-650.
48. Plantaz D., Mohapatra G., Matthay K.K., Pellarin M., Seeger R.C., Feuerstein B.G. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol. 150:1997;81-89.
49. Godfried M.B., Veenstra M., v Sluis P., Boon K., v Asperen R., Hermus M.C., v Schaik B.D., Voute T.P., Schwab M., Versteeg R., Caron H.N. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene. 21:2002;2097-2101.
50. Laureys G., Versteeg R., Speleman F., Van der Drift P., Francke U., Opdenakker G., Van Roy N. Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17) (p36.31-p36.13;q11.2-q12) and neuroblastoma. Eur J Cancer. 31A:1995;523-526.
51. Guo C., White P.S., Weiss M.J., Hogarty M.D., Thompson P.M., Stram D.O., Gerbing R., Matthay K.K., Seeger R.C., Brodeur G.M., Maris J.M. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene. 18:1999;4948-4957.
52. Plantaz D., Vandesompele J., Van Roy N., Lastowska M., Bown N., Combaret V., Favrot M.C., Delattre O., Michon J., Bénard J., Hartmann O., Nicholson J.C., Ross F.M., Brinkschmidt C., Laureys G., Caron H., Matthay K.K., Feuerstein B.G., Speleman F. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification. Int J Cancer. 91:2001;680-686.
53. Koiffmann C.P., Gonzalez C.H., Vianna-Morgante A.M., Kim C.A., Odone-Filho V., Wajntal A. Neuroblastoma in a boy with MCA/MR syndrome, deletion 11q, and duplication 12q. Am J Med Genet. 58:1995;46-49.
54. Pegelow C.H., Ebbin A.J., Powars D., Towner J.W. Familial neuroblastoma. J Pediatr. 87:1975;763-765.
55. Weiss M.J., Guo C., Shusterman S., Hii G., Mirensky T.L., White P.S., Hogarty M.D., Rebbeck T.R., Teare D., Urbanek M., Brodeur G.M., Maris J.M. Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13. Med Pediatr Oncol. 35:2000;526-530.
56. Furuta S., Ohira M., Machida T., Hamano S., Nakagawara A. Analysis of loss of heterozygosity at 16p12-p13 (familial neuroblastoma locus) in 470 neuroblastomas including both sporadic and mass screening tumors. Med Pediatr Oncol. 35:2000;531-533.
57. Nagano H., Kano Y., Kobuchi S., Kajitani T. A case of partial 2p trisomy with neuroblastoma. Jpn J Hum Genet. 25:1980;39-45.
58. Yokoyama Y., Narahara K., Tsuji K., Ninomiya S., Seino Y. Autosomal dominant congenital cataract and microphthalmia associated with a familial t(2;16) translocation. Hum Genet. 90:1992;177-178.
59. Takita J., Hayashi Y., Nakajima T., Adachi J.-I., Tanaka T., Yamaguchi N., Ogawa Y., Hanada R., Yamamoto K., Yokota J. The p16 (CDKN2A) gene is involved in the growth of neuroblastoma cells and its expression is associated with prognosis of neuroblastoma patients. Oncogene. 17:1998;3137-3143.
60. Qureshi F., Jacques S.M., Johnson M.P., Reichler A., Evans M.I. Microscopic neuroblastoma in a fetus with a de novo unbalanced translocation 3;10. Am J Med Genet. 53:1994;24-28.
61. Goodman A.B. Disruption of genes in the retinoid cascade may explain the microscopic neuroblastoma in a fetus with de novo unbalanced translocation (3;10)(q21;q26). [Letter] Am J Med Genet. 56:1995;123.
62. Sanger W.G., Howe J., Fordyce R., Purtilo T. Inherited partial trisomy #15 complicated by neuroblastoma. Cancer Genet Cytogenet. 11:1984;153-159.
63. Goodman A.B. Chromosomal locations and modes of action of genes of the retinoid (vitamin A) system support their involvement in the etiology of schizophrenia. Am J Med Genet. 60:1995;335-348.
64. Donato R. Functional roles of S100 proteins, calcium binding proteins of the EF-hand type. Biochim Biophys Acta. 1450:1999;191-231.
65. Michalski A.J., Cotter F.E., Cowell J.K. Isolation of chromosome-specific DNA sequences from an Alu polymerase chain reaction library to the define the breakpoint in a patient with a constitutional translocation t(1;13)(q22;q12) and ganglioneuroblastoma. Oncogene. 7:1992;1595-1602.
66. Coppes M.J., Egeler R.M. Genetics of Wilms' tumor. Semin Urol Oncol. 17:1999;2-10.
67. Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.S., Toyoda A., Ishii K., Totoki Y., Choi D.K., Groner Y., Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brant P., Scharfe M., Schön O., Desario A., Reichelt J., Kauer G., Blocker H., Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E., Haaf T., Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.L. The DNA sequence of human chromosome 21. Nature. 405:2000;311-319.
68. Scott CS, database manager. The chromosome abnormality database [Internet]. Updated 2002. Search Ref: UID136/RID315-325. Available at: http://www.hgmp.mrc.ac.uk/local-data/Cad_Start.html . Accessed July 2002.
69. Miller R.W. Childhood cancer and congenital defects: a study of US death certificates during the period 1960-1966. Pediatr Res. 3:1969;389-397.
70. Hosoi H., Sawada T., Nakajima T., Kuroda H., Saida T., Sugimoto T., Tokiwa K., Ogita S. A case of mosaic Down's syndrome concomitant with ganglioneuroma. J Pediatr Surg. 24:1989;210-211.
71. Foulkes W.D., Buu P.N., Filiatrault D., Leclerc J.M., Narod S.A. Excess of congenital abnormalities in French-Canadian children with neuroblastoma: a case series study from Montréal. Med Pediatr Oncol. 29:1997;272-279.
72. Trebo M., Klaassen R., Weitzman S. Brief report: neuroblastoma in Down syndrome. Med Pediatr Oncol. 33:1999;125.
73. Al Hermi B.E., Thorner P.S., Arbus G.S. Acute plasmacytic interstitial nephritis in a child with Down syndrome. Pediatr Nephrol. 13:1999;333-335.
74. Mittelbach M., Szekely P. Ein Fall von Neuroblastom des Nebennierenmarkes mit mehreren Missbildungen. Frankfurt Z Pathol. 47:1935;517-521.
75. Miller R.W., Fraumeni J.F. Jr., Hill J.A. Neuroblastoma: epidemiologic approach to its origin. Am J Dis Child. 115:1968;253-261.
76. Nevin N.C., Dodge J.A., Allen I.V. Two cases of trisomy D associated with adrenal tumours. J Med Genet. 9:1972;119-122.
77. Feingold M., Gheradi G.J., Simons C. Familial neuroblastoma and trisomy 13. Am J Dis Child. 121:1971;451.
78. Wertelecki W., Fraumeni J.F., Mulvihill J.J. Nongonadal neoplasia in Turner's syndrome. Cancer. 26:1970;485-488.
79. Maximilian C., Dumitriu L., Garoiu M., Pana I., Serbanescu M., Pop T., Ioan D. Turner's syndrome with sympathoblastoma. Endocrinologie. 21:1983;209-212.
80. Warrier R.P., Kini R.K., Besser A., Vandyke D., Raju U., Kottamasu S. Neuroblastoma with opsomyoclonus and Turner syndrome. Indian J Pediatr. 51:1984;603-605.
81. Fisher P.G., Wechsler D.S., Singer H.S. Anti Hu-antibody in a neuroblastoma-associated on a paraneoplastic syndrome. Pediatr Neurol. 10:1994;309-312.
82. Matsuoka H., Shibata E., Ikezaki A., Kim H.S., Yamazaki K., Murata M. Ganglioneuroma of left adrenal gland in a patient with Turner syndrome during growth hormone therapy. Acta Paediatr Jpn. 39:1997;628-630.
83. Pivnick E.K., Furman W.L., Velagaleti G.V.N., Jenkins J.J., Chase N.A., Ribeiro R.C. Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation. J Med Genet. 35:1998;328-332.
84. Sasaki Y., Nakayama H., Ikeda M. Turner syndrome and ganglioneuroma. J Pediatr Hematol Oncol. 22:2000;89-90.
85. Robinson M.G., McCorquodale M.M. Trisomy 18 and neurogenic neoplasia. J Pediatr. 99:1981;428-429.
86. Mead R.S., Cowell J.K. Molecular characterization of a (1;10)(p22;q21) constitutional translocation from a patient with neuroblastoma. Cancer Genet Cytogenet. 81:1995;151-157.
87. Roberts T., Chernova O., Cowell J.K. Molecular characterization of the 1p22 breakpoint region spanning the constitutional translocation breakpoint in a neuroblastoma patient with a t(1;10)(p22;q21). Cancer Genet Cytogenet. 100:1998;10-20.
88. Roberts T., Chernova O., Cowell J.K. NB4S, a member of the TBC1 domain family of genes, is truncated as a result of a constitutional t(1;10)(p22;q21) chromosome translocation in a patient with stage 4S neuroblastoma. Hum Mol Genet. 7:1998;1169-1178.
89. Pearson A.D.J., Reid M.M., Davison E.V., Bown N., Malcolm A.J., Craft A.W. Cytogenetic investigations of solid tumours of children. Arch Dis Child. 63:1988;1012-1015.
90. White P.S., Maris J.M., Sulman E.P., Jensen S.J., Kyemba S.M., Beltinger C.P., Allen C., Kramer D.L., Biegel J.A., Brodeur G.M. Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma. Eur J Cancer. 33:1997;1957-1961.
91. Anderson J., Kempski H., Hill L., Rampling D., Gordon T., Michalski A. Neuroblastoma in monozygotic twins: a case of probable twin-to-twin metastasis. Br J Cancer. 85:2001;493-496.
92. Say B., Carpenter N.J., Giacoia G., Jegathesan S. Agenesis of the lung associated with a chromosome abnormality (46,XX,2p+). J Med Genet. 17:1980;477-490.
93. Patel J.S., Pearson J., Willatt L., Andrews T., Beach R., Green A. Germline duplication of chromosome 2p and neuroblastoma. J Med Genet. 34:1997;949-951.
94. Yamasaki Y., Sawaguchi S., Kitamura A., Kenmotsu H., Takahashi M., Suganuma Y., Kondo I. A case of neuroblastoma with 3q trisomy. Jpn J Soc Pediatr Surg. 15:1979;667.
95. Maier B., Beck J.D. Dup 3(q) syndrome and neuroblastoma. Eur J Pediatr. 151:1992;715-716.
96. Fryns J.P., Petit P., Moerman F., Cassiman J.J., Van den Berghe H. 8p trisomy in a malformed foetus. Ann Genet. 25:1982;162-163.
97. Hecht F., Kaiser-McCaw B. Chromosomes in familial neuroblastoma. J Pediatr. 98:1981;334.
98. Hecht F., Hecht B.K., Northrup J.C., Trachtenberg N., Wood T.S., Cohen J.D. Genetics of familial neuroblastoma: long range studies. Cancer Genet Cytogenet. 7:1982;227-230.
99. Fryns J.P., Moerman P., Kleczkowska A., Van den Berghe H. Neuroblastoma and partial 15q duplication in the fetus. Ann Genet. 37:1994;42-43.
100. Reitnauer P.J., Rao K.W., Tepperberg J.H., Aylsworth A.S., Powell C.M. Malformation/dysplasia syndrome (neural tube defect, hypospadias, neuroblastoma) associated with an extra dicentric marker chromosome 15 ("inversion duplication 15"). [Abstract] Am J Hum Genet. 55:(suppl 3):1994;A321.
101. Kingston H.M., Nicolini U., Haslam J., Andrews T. 46,XY/47,XY, +17p + mosaicism in amniocytes associated with fetal abnormalities despite normal fetal blood karyotype. Prenat Diagn. 13:1993;637-642.